Ministry of Health: National Stock of COVID-19 Medicines Totals 266.2 Million

The Ministry of Health (Kemenkes) reported that Indonesia's total stock of Covid-19 medications reached 266.2 million units as of January 7, 2022. The most abundant medication was multivitamin tablets, totaling 149.95 million units. Favipiravir tablets followed in second place with 88.9 million units.

Next, there were 13.8 million units of Oseltamivir capsules and 11.87 million units of Azithromycin tablets. According to Kemenkes, 72.2 million units of medication had been distributed to 34 Provincial Health Offices (Dinkes Provinsi) as of January 7, 2022.

The government is striving to ensure that the need for Covid-19 treatment medications is consistently met with optimal availability. The provision of Covid-19 medications is based on the Covid-19 Protocol and takes into account the current case developments.

As of 6 PM on January 8, 2022, a total of 775,804 individuals had received vaccinations. The target for the elderly and public service workers is significantly larger than that for health workers (SDM Kesehatan), with a daily vaccination capacity of 2,536,713.

The public is still urged to diligently adhere to the 3M health protocols: wearing masks, maintaining distance, and washing hands with soap. These health protocols are crucial for preventing the spread of the coronavirus.